Progress in Discovery of KIF5B-RET Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Progress in Discovery of KIF5B-RET Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer

Published:2015-02-04 Issue:9 Volume:58 Page:3672-3681
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Song Minsoo¹

Affiliation:

1. New Drug Development Center (NDDC), Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), 80 Cheombok-ro, Dong-gu, Daegu 701-310, Korea

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm501464c

Reference53 articles.

1. World Cancer Research Fund International.http://www.wcrf.org/index.php(accessed Jan 2, 2015) .

2. National Cancer Institute. Surveillance, Epidemiology, and End Results Program.http://seer.cancer.gov(accessed Jan 2, 2015) .

3. American Cancer Society. Cancer Facts and Figures 2014.http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/(accessed Jan 2, 2015) .

4. Targeted therapy for NSCLC with driver mutations

5. Targeted therapy for non-small-cell lung cancer: past, present and future

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Identification of Potential RET Inhibitors for Targeted Lung Cancer Therapy through Molecular Docking and ADMET Profiling;2024-08-27

2. Small cell lung carcinoma with KIF5B-RET fusion partially responded to the 4^th-line therapy with anlotinib: A case report;World Journal of Clinical Cases;2024-08-16

3. Organometallic–Erlotinib Conjugates Active against Lung Cancer Cells and as Emerging Virus Entry Inhibitors;Organometallics;2024-07-22

4. Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer;AAPS Open;2024-06-17

5. Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations;Journal of Medicinal Chemistry;2024-03-14